Cargando…

Clinical experience of use of (13)C-breath tests in oesophagogastroduodenal diseases: selective questions

INTRODUCTION: Motility disorders can be an important factor in the occurrence of symptoms of dyspepsia that consequently require evaluation of clinical significance of noninvasive diagnostic approaches when observing patients with functional dyspepsia (FD), gastroesophageal reflux disease (GERD), an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shypulin, Vadim, Chernyavskyi, Volodimir, Nechypurenko, Tetyana, Neverovskyi, Artyom, Gvozdecka, Lesya, Mikhn’ova, Natallya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294975/
https://www.ncbi.nlm.nih.gov/pubmed/32550944
http://dx.doi.org/10.5114/pg.2019.90080
_version_ 1783546577628954624
author Shypulin, Vadim
Chernyavskyi, Volodimir
Nechypurenko, Tetyana
Neverovskyi, Artyom
Gvozdecka, Lesya
Mikhn’ova, Natallya
author_facet Shypulin, Vadim
Chernyavskyi, Volodimir
Nechypurenko, Tetyana
Neverovskyi, Artyom
Gvozdecka, Lesya
Mikhn’ova, Natallya
author_sort Shypulin, Vadim
collection PubMed
description INTRODUCTION: Motility disorders can be an important factor in the occurrence of symptoms of dyspepsia that consequently require evaluation of clinical significance of noninvasive diagnostic approaches when observing patients with functional dyspepsia (FD), gastroesophageal reflux disease (GERD), and Helicobacter pylori-associated diseases of the stomach and duodenum. AIM: To determine the relationship between various motility disorders and to improve the diagnostics and treatment with the use of (13)C-urea (UBT) and (13)C-octanoic breath tests (OBT). MATERIAL AND METHODS: A total of 591 patients, aged 18–83 years, who underwent upper gastrointestinal endoscopy at our department were evaluated. Age, sex, and duration of symptoms of dyspepsia were recorded. UBT and OBT were examined in patients with dyspepsia, GERD, and H. pylori-associated diseases. RESULTS: Patients with dyspepsia syndrome had H. pylori infection in 70 ±1.3% of cases. The strategy of “test-and-treat” using UBT can be applied in 76.5% of cases of unexplained dyspepsia in the Ukrainian population. In patients with GERD, slowing down of the gastric emptying (GE) prevails (overall 79.7 ±4.4%), which is a reliable predictor of early relapse of GERD symptoms (OR = 4.9, 2.4–7.0). In the case of H. pylori-associated diseases, the slowing down of GE according to OBT data is a prognostic sign of the return of the symptoms of dyspepsia after successful eradication of H. pylori (OR = 2.1, 1.9–2.3). In H. pylori-associated diseases with a slow GE, recurrence of dyspeptic syndrome after H. pylori-eradication therapy is observed in 33.1% of cases; the appointment of prokinetics reduces this probability to 9.2% (p = 0.0074). CONCLUSIONS: Investigations into the clinical use of new facilities of (13)C-breath tests in gastroenterology are shown. The clinical efficacy of urea and octanoic breath tests in FD, GERD, and H. pylori-associated diseases was proven experimentally among patients of the Ukrainian population. New simplified diagnostic and treatment approaches were proposed for certain groups of patients with gastric dyspepsia syndrome, based on the results of the UBT and the OBT.
format Online
Article
Text
id pubmed-7294975
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-72949752020-06-17 Clinical experience of use of (13)C-breath tests in oesophagogastroduodenal diseases: selective questions Shypulin, Vadim Chernyavskyi, Volodimir Nechypurenko, Tetyana Neverovskyi, Artyom Gvozdecka, Lesya Mikhn’ova, Natallya Prz Gastroenterol Original Paper INTRODUCTION: Motility disorders can be an important factor in the occurrence of symptoms of dyspepsia that consequently require evaluation of clinical significance of noninvasive diagnostic approaches when observing patients with functional dyspepsia (FD), gastroesophageal reflux disease (GERD), and Helicobacter pylori-associated diseases of the stomach and duodenum. AIM: To determine the relationship between various motility disorders and to improve the diagnostics and treatment with the use of (13)C-urea (UBT) and (13)C-octanoic breath tests (OBT). MATERIAL AND METHODS: A total of 591 patients, aged 18–83 years, who underwent upper gastrointestinal endoscopy at our department were evaluated. Age, sex, and duration of symptoms of dyspepsia were recorded. UBT and OBT were examined in patients with dyspepsia, GERD, and H. pylori-associated diseases. RESULTS: Patients with dyspepsia syndrome had H. pylori infection in 70 ±1.3% of cases. The strategy of “test-and-treat” using UBT can be applied in 76.5% of cases of unexplained dyspepsia in the Ukrainian population. In patients with GERD, slowing down of the gastric emptying (GE) prevails (overall 79.7 ±4.4%), which is a reliable predictor of early relapse of GERD symptoms (OR = 4.9, 2.4–7.0). In the case of H. pylori-associated diseases, the slowing down of GE according to OBT data is a prognostic sign of the return of the symptoms of dyspepsia after successful eradication of H. pylori (OR = 2.1, 1.9–2.3). In H. pylori-associated diseases with a slow GE, recurrence of dyspeptic syndrome after H. pylori-eradication therapy is observed in 33.1% of cases; the appointment of prokinetics reduces this probability to 9.2% (p = 0.0074). CONCLUSIONS: Investigations into the clinical use of new facilities of (13)C-breath tests in gastroenterology are shown. The clinical efficacy of urea and octanoic breath tests in FD, GERD, and H. pylori-associated diseases was proven experimentally among patients of the Ukrainian population. New simplified diagnostic and treatment approaches were proposed for certain groups of patients with gastric dyspepsia syndrome, based on the results of the UBT and the OBT. Termedia Publishing House 2019-12-01 2020 /pmc/articles/PMC7294975/ /pubmed/32550944 http://dx.doi.org/10.5114/pg.2019.90080 Text en Copyright: © 2020 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Shypulin, Vadim
Chernyavskyi, Volodimir
Nechypurenko, Tetyana
Neverovskyi, Artyom
Gvozdecka, Lesya
Mikhn’ova, Natallya
Clinical experience of use of (13)C-breath tests in oesophagogastroduodenal diseases: selective questions
title Clinical experience of use of (13)C-breath tests in oesophagogastroduodenal diseases: selective questions
title_full Clinical experience of use of (13)C-breath tests in oesophagogastroduodenal diseases: selective questions
title_fullStr Clinical experience of use of (13)C-breath tests in oesophagogastroduodenal diseases: selective questions
title_full_unstemmed Clinical experience of use of (13)C-breath tests in oesophagogastroduodenal diseases: selective questions
title_short Clinical experience of use of (13)C-breath tests in oesophagogastroduodenal diseases: selective questions
title_sort clinical experience of use of (13)c-breath tests in oesophagogastroduodenal diseases: selective questions
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294975/
https://www.ncbi.nlm.nih.gov/pubmed/32550944
http://dx.doi.org/10.5114/pg.2019.90080
work_keys_str_mv AT shypulinvadim clinicalexperienceofuseof13cbreathtestsinoesophagogastroduodenaldiseasesselectivequestions
AT chernyavskyivolodimir clinicalexperienceofuseof13cbreathtestsinoesophagogastroduodenaldiseasesselectivequestions
AT nechypurenkotetyana clinicalexperienceofuseof13cbreathtestsinoesophagogastroduodenaldiseasesselectivequestions
AT neverovskyiartyom clinicalexperienceofuseof13cbreathtestsinoesophagogastroduodenaldiseasesselectivequestions
AT gvozdeckalesya clinicalexperienceofuseof13cbreathtestsinoesophagogastroduodenaldiseasesselectivequestions
AT mikhnovanatallya clinicalexperienceofuseof13cbreathtestsinoesophagogastroduodenaldiseasesselectivequestions